DCISionRT gives us the opportunity to have a more informed discussion with our DCIS patients.

“For DCIS patients we don’t want to treat and subject patients to the side effects of radiation if the risk benefit ratio is low. That is why I am really excited about DCISionRT. DCISionRT is a risk assessment tool that looks at the patient’s tumor biology to determine an individual patient’s benefit of radiation therapy following breast conserving surgery, as well as the patient’s risk of DCIS recurring or progressing to invasive cancer.”